These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 16360968)
1. The utility of microvascular perfusion assessment in heart failure: a pilot study. Hogan CJ; Hess ML; Ward KR; Gennings C J Card Fail; 2005 Dec; 11(9):713-9. PubMed ID: 16360968 [TBL] [Abstract][Full Text] [Related]
2. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Opasich C; Pinna GD; Mazza A; Febo O; Riccardi R; Riccardi PG; Capomolla S; Forni G; Cobelli F; Tavazzi L Eur Heart J; 2001 Mar; 22(6):488-96. PubMed ID: 11237544 [TBL] [Abstract][Full Text] [Related]
3. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493 [TBL] [Abstract][Full Text] [Related]
4. Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure. Stanton EB; Hansen MS; Sole MJ; Gawad Y; Packer M; Pitt B; Swedberg K; Rouleau JL; Can J Cardiol; 2005 Jan; 21(1):39-43. PubMed ID: 15685301 [TBL] [Abstract][Full Text] [Related]
5. Alveolar--capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Guazzi M; Pontone G; Brambilla R; Agostoni P; Rèina G Eur Heart J; 2002 Mar; 23(6):467-76. PubMed ID: 11863349 [TBL] [Abstract][Full Text] [Related]
6. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure. Majani G; Pierobon A; Pinna GD; Giardini A; Maestri R; La Rovere MT Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):836-42. PubMed ID: 21450593 [TBL] [Abstract][Full Text] [Related]
7. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study. Demir M; Kanadasi M; Akpinar O; Dönmez Y; Avkarogullari M; Alhan C; Inal T; San M; Usal A; Demirtas M Angiology; 2007; 58(5):603-9. PubMed ID: 18024945 [TBL] [Abstract][Full Text] [Related]
8. Absence of exercise capacity improvement after exercise training program: a strong prognostic factor in patients with chronic heart failure. Tabet JY; Meurin P; Beauvais F; Weber H; Renaud N; Thabut G; Cohen-Solal A; Logeart D; Ben Driss A Circ Heart Fail; 2008 Nov; 1(4):220-6. PubMed ID: 19808295 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure. Ingle L; Goode K; Carroll S; Sloan R; Boyes C; Cleland JG; Clark AL Int J Cardiol; 2007 Jun; 118(3):350-5. PubMed ID: 17067694 [TBL] [Abstract][Full Text] [Related]
10. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure. Iwaoka M; Obata JE; Abe M; Nakamura T; Kitta Y; Kodama Y; Kawabata K; Takano H; Fujioka D; Saito Y; Kobayashi T; Hasebe H; Kugiyama K J Card Fail; 2007 May; 13(4):247-53. PubMed ID: 17517342 [TBL] [Abstract][Full Text] [Related]
11. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Florea VG; Henein MY; Anker SD; Francis DP; Chambers JS; Ponikowski P; Coats AJ Eur Heart J; 2000 Jan; 21(2):146-53. PubMed ID: 10637088 [TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of results from clinical tests, echocardiographic, electrocardiographic and spiro-ergometric exercise test examinations in patients with heart failure]. Tomkiewicz-Pajak L; Podolec P; Kostkiewicz M; Tracz W; Suchoń E; Krochin M Przegl Lek; 2002; 59(8):572-6. PubMed ID: 12638322 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E; Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173 [TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918 [TBL] [Abstract][Full Text] [Related]
17. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. Packer M; Abraham WT; Mehra MR; Yancy CW; Lawless CE; Mitchell JE; Smart FW; Bijou R; O'Connor CM; Massie BM; Pina IL; Greenberg BH; Young JB; Fishbein DP; Hauptman PJ; Bourge RC; Strobeck JE; Murali S; Schocken D; Teerlink JR; Levy WC; Trupp RJ; Silver MA; J Am Coll Cardiol; 2006 Jun; 47(11):2245-52. PubMed ID: 16750691 [TBL] [Abstract][Full Text] [Related]
18. End-stage heart failure: is there a role for the Batista procedure? Frota Filho JD; Pereira WM; Leães PE; Blacher C; Jung LA; Lucchese F Heart Surg Forum; 1998; 1(1):41-8. PubMed ID: 11276439 [TBL] [Abstract][Full Text] [Related]
19. The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies. Stempfle HU; Alt A; Stief J; Siebert U J Heart Lung Transplant; 2008 Feb; 27(2):222-8. PubMed ID: 18267231 [TBL] [Abstract][Full Text] [Related]
20. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]